Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Jim Roof who wrote (15)	2/20/1998 6:55:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 4634

<<Please tell me precisely how the studies were faked? >> I don't believe I ever said the studies were "faked". However; IN MY OPINION, I think that management has taken selective data out of context to make it appear that hextend has therapeutic properties which it really doesn't. I also believe that management is falsely trying to establish some causal relationship between the addition of electrolytes in hextend and these therapeutic properties. <<Please tell me why the insiders have chosen to ride out the decline from 27 to 12 rather than liquidate at least a portion of their shares on the backs of the severely scammed?>> I already pointed out the SEC 13D filings. It is also a fact that Josh Steinberg (from Individual investor) was selling the stock at the same time he was urging his readers to buy. In fact, not only did he sell, but he shorted additional shares. <<At first glance one would assume that this is a strong negative because we need platelets to clot and hemoglobin to oxygenate but there is a very powerful hidden positive tidbit hidden from your eyes here. That is the fact that these patients had these lower numbers because their systems better tolerated higher levels of the expander than did the hespan/hetastarch group. Ie., Hextend patients did not need to receive as much transfused blood or platelets during and after their surgery. Their blood clotted fine with less platelets and Hextend than did the hespan patients with MORE platelets.>> You are jumping to conclusions here. There is absolutely NO scientific evidence that this is the case. You can't establish a causal relationship just because you wish it to be so. <<Any claim to the contrary is simply an unsupported opinion or is patently dishonest.>> I see. So YOU are the sole arbiter of truth regarding this company. Bravo.